2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and PK of UI018 administration of UI018, co-administration of UIC201806 and UIC201602 - Hyperlipemia, Mixed | Phase 1 | Unknown | Korea United Pharm. Inc. | 44 | 2021-09-06 | 2021-12-21 |
| Phase I Drug-drug Interaction of Omega-3 and Atorvastatin Omacor, Pritor, Omacor + Pritor - Hyperlipidemia, Hypertriglyceridemia | Phase 1 | Unknown | DongKoo Bio & Pharma | 48 | 2018-02-01 | 2018-02-22 |
Hyperlipidemias (1) · Hyperlipoproteinemia Type V (1)
Dyslipidemias (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hyperlipidemias (1) · Hyperlipoproteinemias (1) · Lipid Metabolism, Inborn Errors (1) · Metabolism, Inborn Errors (1)
Omacor (1) · Telmisartan (1)
DongKoo Bio & Pharma (1) · Korea United Pharm. Inc. (1)
South Korea (2)
Injin Jang, Dr. (1) · Min Kyu Park, MD (1)